155 related articles for article (PubMed ID: 8662922)
1. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII.
Esmon CT; Lollar P
J Biol Chem; 1996 Jun; 271(23):13882-7. PubMed ID: 8662922
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
Ofosu FA
Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
[TBL] [Abstract][Full Text] [Related]
3. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
Bukys MA; Orban T; Kim PY; Beck DO; Nesheim ME; Kalafatis M
J Biol Chem; 2006 Jul; 281(27):18569-80. PubMed ID: 16624813
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
Newell JL; Fay PJ
J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
[TBL] [Abstract][Full Text] [Related]
5. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
Liu LW; Ye J; Johnson AE; Esmon CT
J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
[TBL] [Abstract][Full Text] [Related]
7. Acidic residues C-terminal to the A2 domain facilitate thrombin-catalyzed activation of factor VIII.
Newell JL; Fay PJ
Biochemistry; 2008 Aug; 47(33):8786-95. PubMed ID: 18642885
[TBL] [Abstract][Full Text] [Related]
8. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
9. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
[TBL] [Abstract][Full Text] [Related]
10. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments.
Dharmawardana KR; Olson ST; Bock PE
J Biol Chem; 1999 Jun; 274(26):18635-43. PubMed ID: 10373475
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements for the activation of human factor VIII by thrombin.
Myles T; Yun TH; Leung LL
Blood; 2002 Oct; 100(8):2820-6. PubMed ID: 12351390
[TBL] [Abstract][Full Text] [Related]
13. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
Ye J; Liu LW; Esmon CT; Johnson AE
J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.
Corral-Rodríguez MÁ; Bock PE; Hernández-Carvajal E; Gutiérrez-Gallego R; Fuentes-Prior P
Blood; 2011 Jun; 117(26):7164-73. PubMed ID: 21555742
[TBL] [Abstract][Full Text] [Related]
15. Polyphosphate binds with high affinity to exosite II of thrombin.
Mutch NJ; Myles T; Leung LL; Morrissey JH
J Thromb Haemost; 2010 Mar; 8(3):548-55. PubMed ID: 20002544
[TBL] [Abstract][Full Text] [Related]
16. The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin.
Chahal G; Thorpe M; Hellman L
PLoS One; 2015; 10(6):e0129511. PubMed ID: 26110612
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
Dharmawardana KR; Bock PE
Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
[TBL] [Abstract][Full Text] [Related]
18. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.
Pieters J; Lindhout T; Hemker HC
Blood; 1989 Aug; 74(3):1021-4. PubMed ID: 2502206
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis.
Iwanaga S; Okada M; Isawa H; Morita A; Yuda M; Chinzei Y
Eur J Biochem; 2003 May; 270(9):1926-34. PubMed ID: 12709051
[TBL] [Abstract][Full Text] [Related]
20. Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain.
Nogami K; Zhou Q; Myles T; Leung LL; Wakabayashi H; Fay PJ
J Biol Chem; 2005 May; 280(18):18476-87. PubMed ID: 15746105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
